Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Kymera Therapeutics Inc
NASDAQ:KYMR
Kymera Therapeutics Inc
NASDAQ:KYMR
Price:
110.49
USD
0.34%
Market Cap:
$9.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Kymera Therapeutics Inc
NASDAQ:KYMR
|
US |
|
C
|
China Construction Bank Corp
DUS:C6T
|
CN |
|
BNP Paribas SA
PAR:BNP
|
FR |
|
S
|
Sparebank 1 Ostfold Akershus
OSE:SOAG
|
NO |
|
N
|
Nippon Yusen KK
DUS:NYKA
|
JP |
Wall St Price Targets
KYMR Price Forecast
Based on 24 analysts
Based on 24 analysts
+24% Upside
from
$110.49
today
Kymera Therapeutics Inc (KYMR)’s 12-month stock price forecast through October 2027 has a consensus target of $136.68, implying 24% upside. The forecast is based on price targets from 24 Wall Street analysts.
KYMR Analyst Rating
Based on 20 analysts
Based on 20 analysts
Analysts rate KYMR Strong buy, with 17 of 20 recommending Buy or Strong buy.
Kymera Therapeutics Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is KYMR's stock price target?
Price Target
136.68
USD
136.68
USD
According to Wall Street analysts, the average 1-year price target for KYMR is 136.68 USD with a low forecast of 112.11 USD and a high forecast of 189 USD.
What is the Revenue forecast for Kymera Therapeutics Inc?
Projected CAGR
73%
73%
Over the last 6 years, the compound annual growth rate for Revenue has been 54%. The projected CAGR for the next 8 years is 73%.